Abstract
Hyperinsulinemia is a risk factor in atherosclerosis formation that it stimulated vascular smooth muscle cells (VSMCs) proliferation and migration. To understand the underlying molecular mechanism involved in the processes of cellular response to insulin, VSMCs from Wistar-Kyoto rat (WKY) and spontaneous hypertensive rat (SHR) were isolated and cultured, and its proteome was comparatively analyzed with normal control by two-dimensional gel electrophoresis (2-DE). Results showed that the proliferation of VSMCs from SHR be more sensitive to insulin stimulation than that VSMCs from WKY. The detectable spots ranged from 537 to 608 on the gels in VSMCs of SHR, and 413 ± 31 spots in VSMCs of WKY. The different expressed protein spots in VSMCs of SHR were then isolated and measured by matrix-assisted desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS). A total of 18 spots showed a sharp clear spectrum, and 13 spots matched with the known proteins from database. These proteins were mainly involved in cytoskeleton, glycometabolism, and post-translational processes. Among these proteins, OPN and matrix gla protein were up-regulated expression proteins, while α-SM actin was down-regulated. Furthermore, these preliminarily identified proteins confirmed by RT-PCR and western blotting analysis were coincident with the changes in 2-DE check. In addition, the cytoskeleton changes and migration rate of VSMCs from SHR treated by insulin increased significantly. The results showed that insulin plays a crucial role in activating proliferation and migration of VSMCs, by regulating the phenotype switch of VSMCs.
Similar content being viewed by others
Abbreviations
- VSMC:
-
Vascular smooth muscle cells
- 2-DE:
-
Two-dimensional gel electrophoresis
- MALDI-TOF-MS:
-
Matrix-assisted desorption/ionization time of flight mass spectrometry
- SHR:
-
Spontaneous hypertensive rat
- WKY:
-
Wistar-Kyoto rat
- α-SM actin:
-
α-Smooth muscle actin
- OPN:
-
Osteopontin
References
Yamada, H., Tsushima, T., Murakami, H., Uchigata, Y., & Iwamoto, Y. (2002). Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells. International Journal of Experimental Diabetes Research, 3, 131–144.
Doronzo, G., Russo, I., Mattiello, L., Anfossi, G., Bosia, A., & Trovati, M. (2004). Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: Influence of nitric oxide and of insulin resistance. European Journal of Clinical Investigation, 34, 664–673.
Sourij, H., Schmoelzer, I., Dittrich, P., Paulweber, B., Iglseder, B., & Wascher, T. C. (2008). Insulin resistance as a risk factor for carotid atherosclerosis: A comparison of the homeostasis model assessment and the short insulin tolerance test. Stroke, 39, 1349–1351.
Pyörälä, M., Miettinen, H., Halonen, P., Laakso, M., & Pyörälä, K. (2000). Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki policemen study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 538–544.
Doronzo, G., Russo, I., Mattiello, L., Riganti, C., Anfossi, G., & Trovati, M. (2006). Insulin activates hypoxia-inducible factor-1 alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: Impairment in insulin resistance owing to defects in insulin signaling. Diabetologia, 49, 1049–1063.
Wang, C. C., Gurevich, I., & Draznin, B. (2003). Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes, 52, 2562–2569.
Deng, D. X., Spin, J. M., Tsalenko, A., Vailaya, A., Ben-Dor, A., Yakhini, Z., et al. (2006). Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: Distinct responses to stimuli. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1058–1065.
Rzucidlo, E. M., Martin, K. A., & Powell, R. J. (2007). Regulation of vascular smooth muscle cell differentiation. Journal of Vascular Surgery, 45(Suppl A), 25A–32A.
Pandolfi, A., Grilli, A., Cilli, C., Patruno, A., Giaccari, A., Di Silvestre, S., et al. (2003). Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: Association with increased nitric oxide synthase expression and superoxide anion generation. Journal of Cellular Physiology, 196, 378–385.
Hayashi, K., Shibata, K., Morita, T., Iwasaki, K., Watanabe, M., & Sobue, K. (2004). Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. The Journal of Biological Chemistry, 279, 40807–40818.
Muñoz, F. J., Jiménez, M., Melón, J., & Ruiz-Torres, A. (1998). Phenotypic changes in vascular smooth muscle cells during aging: Insulin effect on migration. Gerontology, 44, 149–152.
Faries, P. L., Rohan, D. I., Wyers, M. C., Marin, M. L., Hollier, L. H., Quist, W. C., et al. (2002). Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. Journal of Surgical Research, 104, 22–28.
Yasunari, K., Kohno, M., Kano, H., Yokokawa, K., Minami, M., & Yoshikawa, J. (1999). Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation, 99, 1370–1378.
Arnqvist, H. J., Bornfeldt, K. E., Chen, Y., & Lindström, T. (1995). The insulin-like growth factor system in vascular smooth muscle: Interaction with insulin and growth factors. Metabolism, 44, 58–66.
Okuda, T., Sumiya, T., Mizutani, K., Tago, N., Miyata, T., Tanabe, T., et al. (2002). Analyses of differential gene expression in genetic hypertensive rats by microarray. Hypertension Research, 25, 249–255.
Boccardi, C., Cecchettini, A., Caselli, A., Camici, G., Evangelista, M., Mercatanti, A., et al. (2007). A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell and Tissue Research, 329, 119–128.
Fukuda, N., Hu, W. Y., Satoh, C., Nakayama, M., Kishioka, H., Kubo, A., et al. (1999). Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. Journal of Hypertension, 17, 1099–1107.
King, K. E., Iyemere, V. P., Weissberg, P. L., & Shanahan, C. M. (2003). Krüppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. The Journal of Biological Chemistry, 278, 11661–11669.
Ross, R. (1971). The smooth muscle cell: II Growth of smooth muscle in culture and formation of elastic fibers. Journal of Cell Biology, 50, 172–186.
Liu, S., Zhang, Y., Xie, X., Hu, W., Cai, R., Kang, J., et al. (2007). Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat. Cellular and Molecular Immunology, 4, 65–70.
Shanahan, C. M., Cary, N. R., Osbourn, J. K., & Weissberg, P. L. (1997). Identification of osteoglycin as a component of the vascular matrix differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2437–2447.
Hu, W. Y., Fukuda, N., Ikeda, Y., Suzuki, R., Tahira, Y., Takagi, H., et al. (2003). Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype. Journal of Cellular Physiology, 196, 284–292.
Hao, H., Ropraz, P., Verin, V., Camenzind, E., Geinoz, A., Pepper, M. S., et al. (2002). Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1093–1099.
Chadjichristos, C. E., Morel, S., Derouette, J. P., Sutter, E., Roth, I., Brisset, A. C., et al. (2008). Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circulation Research, 102, 653–660.
Lin, Z. H., Fukuda, N., Jin, X. Q., Yao, E. H., Ueno, T., Endo, M., et al. (2004). Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension, 44, 42–47.
Begum, N., & Ragolia, L. (2000). High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. American Journal of Physiology. Cell Physiology, 278, C81–C91.
Opitz, F., Schenke-Layland, K., Cohnert, T. U., & Stock, U. A. (2007). Phenotypical plasticity of vascular smooth muscle cells-effect of in vitro and in vivo shear stress for tissue engineering of blood vessels. Tissue Engineering, 13, 2505–2514.
Duan, C. (2003). The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2. Molecular and Cellular Endocrinology, 206, 75–83.
Meng, D., Lv, D. D., & Fang, J. (2008). Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovascular Research, 80, 299–308.
Radhakrishnan, Y., Maile, L. A., Ling, Y., Graves, L. M., & Clemmons, D. R. (2008). Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. The Journal of Biological Chemistry, 283, 16320–16331.
Lim, H. J., Park, H. Y., Ko, Y. G., Lee, S. H., Cho, S. Y., Lee, E. J., et al. (2004). Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis. Biochemical and Biophysical Research Communications, 325, 1106–1114.
Shanahan, C. M., Weissberg, P. L., & Metcalfe, J. C. (1993). Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circulation Research, 73, 193–204.
Kaartinen, M. T., Murshed, M., Karsenty, G., & McKee, M. D. (2007). Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. Journal of Histochemistry and Cytochemistry, 55, 375–386.
Steitz, S. A., Speer, M. Y., Curinga, G., Yang, H. Y., Haynes, P., Aebersold, R., et al. (2001). Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circulation Research, 89, 1147–1154.
Abe, K., Nakashima, H., Ishida, M., Miho, N., Sawano, M., Soe, N. N., et al. (2008). Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1. Hypertension Research, 31, 987–998.
Boccardi, C., Cecchettini, A., Caselli, A., Camici, G., Evangelista, M., Mercatanti, A., et al. (2007). A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell and Tissue Research, 328, 185–195.
Acknowledgments
This work was supported by two grants from the National Science Foundation of China (No. 30570764 and No 30772281). The authors thank Wei Sun (Central Lab of Third Military Medical University, Chongqing, China) for technical support on confocal images.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Y., Zhang, B., Bai, Y. et al. Changes in Proteomic Features Induced by Insulin on Vascular Smooth Muscle Cells from Spontaneous Hypertensive Rats In Vitro. Cell Biochem Biophys 58, 97–106 (2010). https://doi.org/10.1007/s12013-010-9096-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-010-9096-x